DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Kudo M, Finn RS, Edeline J. et al.
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC).
J Clin Oncol 2020;
38 (04) 518
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.